Amide Linkage Cyclic Natriuretic Peptide Constructs
    11.
    发明申请
    Amide Linkage Cyclic Natriuretic Peptide Constructs 有权
    酰胺连接循环利钠肽构建体

    公开(公告)号:US20100035821A1

    公开(公告)日:2010-02-11

    申请号:US12572284

    申请日:2009-10-02

    IPC分类号: A61K38/10 C07K7/08 A61P9/10

    CPC分类号: C07K14/58 A61K38/00

    摘要: Cyclic constructs which bind to a natriuretic peptide receptor and include a plurality of amino acid residues, at least one amino acid surrogate of formula I: where R, R′, Q, Y, W, Z, J, x and n are as defined in the specification, and a cyclic linkage including one or two amide bonds, pharmaceutical compositions including such cyclic constructs, and methods of treating congestive heart failure or other conditions, syndromes or diseases for which induction of anti-hypertensive, cardiovascular, renal or endocrine effects are desired.

    摘要翻译: 结合利尿钠肽受体并包含多个氨基酸残基的至少一种氨基酸替代物,其中R,R',Q,Y,W,Z,J,x和n如上所定义, 在本说明书中,包括一个或两个酰胺键的环状连接,包括这种环状构建体的药物组合物,治疗充血性心力衰竭或其它病症的方法,综合征或诱导抗高血压,心血管,肾脏或内分泌效应的疾病 是理想的。

    Linear and Cyclic Melanocortin Receptor-Specific Peptidomimetics
    12.
    发明申请
    Linear and Cyclic Melanocortin Receptor-Specific Peptidomimetics 有权
    线性和环状黑皮素受体特异性肽模拟物

    公开(公告)号:US20090069224A1

    公开(公告)日:2009-03-12

    申请号:US12244880

    申请日:2008-10-03

    IPC分类号: A61K38/12 C07K7/54

    摘要: Linear and cyclic peptidomimetics which bind to one or more melanocortin receptors are provided, which peptidomimetics include at least one ring-constrained amino acid surrogate of formula I: where R1, R2, R3, R4, R5, R6, R7, R8, and y are as defined in the specification, together with methods for synthesizing ring-constrained amino acid surrogates of formula I and peptidomimetics incorporating the same, and methods of use of peptidomimetics in the treatment of various diseases, syndromes and conditions.

    摘要翻译: 提供了结合一种或多种黑皮质素受体的线性和环肽模拟物,其中肽模拟物包括至少一个式I的环受限氨基酸替代物:其中R1,R2,R3,R4,R5,R6,R7,R8和y 以及用于合成式I的环受限制的氨基酸替代物的方法和包含其的肽模拟物的方法,以及使用肽模拟物治疗各种疾病,综合征和病症的方法。

    Opioid metallopeptide compositions and methods
    13.
    发明授权
    Opioid metallopeptide compositions and methods 失效
    阿片类金属肽组合物和方法

    公开(公告)号:US06979436B2

    公开(公告)日:2005-12-27

    申请号:US10150979

    申请日:2002-05-17

    摘要: Metallopeptides and metallopeptide combinatorial libraries specific for opioids receptors are provided, for use in biological, pharmaceutical and related applications. The metallopeptides and combinatorial libraries are made of peptides, peptidomimetics and peptide-like constructs, in which the peptide, peptidomimetic or construct is conformationally fixed in a biologically active configuration specific for one or more opioid receptors on complexation of a metal ion-binding portion thereof with a metal ion.

    摘要翻译: 提供了对阿片类受体特异性的金属肽和金属肽组合文库,用于生物,药物和相关应用。 金属肽和组合文库由肽,肽模拟物和肽样构建体制成,其中肽,拟肽或构建体在一种或多种阿片受体特异性的生物活性构型中被构象地固定在金属离子结合部分的络合物上 与金属离子。

    Amide linkage cyclic natriuretic peptide constructs
    14.
    发明授权
    Amide linkage cyclic natriuretic peptide constructs 有权
    酰胺连接环状钠尿肽构建体

    公开(公告)号:US08580746B2

    公开(公告)日:2013-11-12

    申请号:US12572284

    申请日:2009-10-02

    IPC分类号: A61K38/10 A61K38/12

    CPC分类号: C07K14/58 A61K38/00

    摘要: Cyclic constructs which bind to a natriuretic peptide receptor and include a plurality of amino acid residues, at least one amino acid surrogate of formula I: where R, R′, Q, Y, W, Z, J, x and n are as defined in the specification, and a cyclic linkage including one or two amide bonds, pharmaceutical compositions including such cyclic constructs, and methods of treating congestive heart failure or other conditions, syndromes or diseases for which induction of anti-hypertensive, cardiovascular, renal or endocrine effects are desired.

    摘要翻译: 结合利尿钠肽受体并包含多个氨基酸残基的至少一种氨基酸替代物,其中R,R',Q,Y,W,Z,J,x和n如上所定义, 在本说明书中,包括一个或两个酰胺键的环状连接,包括这种环状构建体的药物组合物,治疗充血性心力衰竭或其它病症的方法,综合征或诱导抗高血压,心血管,肾脏或内分泌效应的疾病 是理想的。

    Amino acid surrogates for peptidic constructs
    15.
    发明授权
    Amino acid surrogates for peptidic constructs 有权
    氨基酸替代肽结构

    公开(公告)号:US07964181B2

    公开(公告)日:2011-06-21

    申请号:US11694181

    申请日:2007-03-30

    CPC分类号: C07K14/58 C07D403/04 C07K7/16

    摘要: Ring-constrained amino acid surrogates of formula I: where R1, R2, R3, R4, R5, R6a, R6b, R7, and y are as defined in the specification, methods for synthesizing ring-constrained amino acid surrogates of formula I, methods of use of ring-constrained amino acid surrogates of formula I, including use in linear or cyclic compounds which include a plurality of amino acid residues and one or more ring-constrained amino acid surrogates of formula I and linear or cyclic compounds which include a plurality of amino acid residues and one or more ring-constrained amino acid surrogates of formula I.

    摘要翻译: 式I的环受限氨基酸替代物:其中R1,R2,R3,R4,R5,R6a,R6b,R7和y如本说明书中所定义,用于合成式I的环受限氨基酸替代物的方法,方法 包括用于包括多个氨基酸残基和一个或多个式I的环受约束的氨基酸替代物的直链或环状化合物的线形或环状化合物,其包括多个 的氨基酸残基和一个或多个式I的环受限氨基酸替代物。

    Cyclic Peptide Compositions for Treatment of Sexual Dysfunction
    17.
    发明申请
    Cyclic Peptide Compositions for Treatment of Sexual Dysfunction 有权
    用于治疗性功能障碍的环肽组合物

    公开(公告)号:US20100121027A1

    公开(公告)日:2010-05-13

    申请号:US12348489

    申请日:2009-01-05

    IPC分类号: C07K7/64

    摘要: A cyclic peptide of the structural formula: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, m and p are as defined. Further provided are compositions for treatment of sexual dysfunction in mammals, including male sexual dysfunction, such as erectile dysfunction, and female sexual dysfunction, by administration of a cyclic peptide including a C-terminus —OH group. Routes of administration include injection, oral, urethral, vaginal, nasal and mucosal administration.

    摘要翻译: 结构式的环状肽或其药学上可接受的盐,其中R 1,R 2,R 3,R 4,R 5,R 6,m和p如上所定义。 还提供了通过施用包括C末端-OH基团的环肽来治疗哺乳动物的性功能障碍的组合物,包括男性性功能障碍,例如勃起功能障碍和女性性功能障碍。 给药途径包括注射,口服,尿道,阴道,鼻和粘膜给药。

    Cyclic peptide compositions for treatment of sexual dysfunction
    18.
    发明授权
    Cyclic peptide compositions for treatment of sexual dysfunction 有权
    用于治疗性功能障碍的循环肽组合物

    公开(公告)号:US07473760B2

    公开(公告)日:2009-01-06

    申请号:US11269271

    申请日:2005-11-09

    IPC分类号: A61K38/00 A61K38/12 C07K7/00

    摘要: A cyclic peptide of the structural formula: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, R6, m, n and p are as defined. Further provided are compositions for treatment of sexual dysfunction in mammals, including male sexual dysfunction, such as erectile dysfunction, and female sexual dysfunction, by administration of a cyclic peptide including a C-terminus —OH group. Routes of administration include injection, oral, urethral, vaginal, nasal and mucosal administration.

    摘要翻译: 结构式的环状肽或其药学上可接受的盐,其中R 1,R 2,R 3,R 5,R 6,m,n和p如上所定义。 还提供了通过施用包括C末端-OH基团的环肽来治疗哺乳动物的性功能障碍的组合物,包括男性性功能障碍,例如勃起功能障碍和女性性功能障碍。 给药途径包括注射,口服,尿道,阴道,鼻和粘膜给药。

    Cyclic natriuretic peptide constructs

    公开(公告)号:US08580747B2

    公开(公告)日:2013-11-12

    申请号:US12622055

    申请日:2009-11-19

    IPC分类号: A61K38/10 A61K38/12

    CPC分类号: C07K14/58

    摘要: Cyclic constructs with an N-terminus and a C-terminus which bind to a natriuretic peptide receptor and include a plurality of amino acid residues, at least one amino acid surrogate of formula I: where R, R′, Q, Y, W, Z, J, x and n are as defined in the specification, and optionally at least one prosthetic group, pharmaceutical compositions including such cyclic constructs, and methods of treating congestive heart failure or other conditions, syndromes or diseases for which induction of anti-hypertensive, cardiovascular, renal or endocrine effects are desired.